4.3 Article

Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer

Journal

ONCOTARGET
Volume 7, Issue 52, Pages 86039-86050

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.13325

Keywords

IFITM1; colorectal cancer; prognosis; metastasis

Funding

  1. Soonchunhyang University Research Fund
  2. Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHID) - Ministry of Health & Welfare, Republic of Korea [HI15C1647]

Ask authors/readers for more resources

Interferon-induced transmembrane protein 1 (IFITM1) has been shown to be implicated in multiple cancers, yet little is known about biological significance of IFITM1 in colorectal cancer. Here, we show that IFITM1 is highly expressed in metastatic colorectal cancer cell lines as well as colorectal patient-derived tumor samples, and its expression is associated with a poor prognosis of the disease. Also, IFITM1 depletion resulted in a significant reduction in the mobility of cancer cell lines, whereas ectopic expression of IFITM1 promoted the migration of cancer cells. Epithelial-mesenchymal transition (EMT) signature was dysregulated by both loss and gain of function of IFITM1, which was partially reverted by Caveolin-1 (CAV1). Therefore, these results suggest that IFITM1 may be a prognostic marker and an attractive target to achieve better therapeutic outcomes in colorectal cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pathology

Downregulation of miR-9 correlates with poor prognosis in colorectal cancer

Hyeongjoo Kim, Taewan Kim, Gunn Jaygal, Jongsoo Woo, Chang-Jin Kim, Moo-Jun Baek, Dongjun Jeong

PATHOLOGY RESEARCH AND PRACTICE (2020)

Article Biochemistry & Molecular Biology

AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth

Ita Novita Sari, Ying-Gui Yang, Yoseph Toni Wijaya, Nayoung Jun, Sanghyun Lee, Kwang Seock Kim, Jeevisha Bajaj, Vivian G. Oehler, Soo-Hyun Kim, Soo-Young Choi, Sa-Hee Park, Dong-Wook Kim, Tannishtha Reya, Jaeseok Han, Hyog Young Kwon

Summary: AMD1 plays a crucial role in the progression of myeloid leukemia, and its depletion leads to differentiation of leukemic stem cells and impairs leukemia progression. Pharmacological inhibition of AMD1 can significantly reduce the progression of leukemia cells, offering a new therapeutic approach for the treatment of myeloid leukemia.

ONCOGENE (2021)

Article Oncology

Expression of AMP-activated protein kinase/ten-eleven translocation 2 and their clinical relevance in colorectal cancer

Dong Hyun Kang, Dong Jun Jeong, Tae Sung Ahn, Hyun Yong Lee, Han Jo Kim, Sang Byung Bae, Hyeong Joo Kim, Moon Soo Lee, Hyog Young Kwon, Moo-Jun Baek

Summary: High expression levels of TET2 in colorectal cancer are associated with favorable prognosis, while AMPK expression levels do not significantly impact patient survival. Further functional analysis of AMPK/TET2 expression in CRC is necessary to better understand its clinical significance.

ONCOLOGY LETTERS (2021)

Article Pharmacology & Pharmacy

Intracellular delivery of oxaliplatin conjugate via cell penetrating peptide for the treatment of colorectal carcinoma in vitro and in vivo

Tejinder Singh, Dong Hyun Kang, Tae Wan Kim, Hye Jeong Kong, Jae Sung Ryu, Seob Jeon, Tae Sung Ahn, Dongjun Jeong, Moo Jun Baek, Jungkyun Im

Summary: The octaarginine-oxaliplatin conjugate successfully delivered oxaliplatin into colon cancer cells at low concentrations, showing high antitumor activity in both in vitro and in vivo studies. This strategy may provide a new approach for designing oxaliplatin derivatives with improved therapeutic capabilities.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Oncology

Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment

Takashi Semba, Xiaoping Wang, Xuemei Xie, Evan N. Cohen, James M. Reuben, Kevin N. Dalby, James P. Long, Lan Thi Hanh Phi, Debu Tripathy, Naoto T. Ueno

Summary: The study identified that high phosphorylated JNK level in TNBC is associated with increased Treg infiltration. Inhibition of JNK signaling led to reduced tumor growth and Treg infiltration, and increased CD8(+) T cell infiltration, possibly through suppression of CCL2 secretion. This suggests that targeting the JNK/C-JUN/CCL2 axis may offer new therapeutic strategies for combating the aggressiveness of TNBC.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Metabolism and function of polyamines in cancer progression

Ita Novita Sari, Tania Setiawan, Kwang Seock Kim, Yoseph Toni Wijaya, Kae Won Cho, Hyog Young Kwon

Summary: Polyamines, essential for the proliferation and development of eukaryotes, are low-molecular-weight organic polycations with strict intracellular regulation. In cancer, dysregulation of polyamine metabolism leads to elevated levels and interactions with oncogenic pathways like mTOR and RAS, making them potential therapeutic targets. Unraveling the molecular mechanisms linking polyamine metabolism to carcinogenesis is crucial for developing novel inhibitors and understanding the findings of clinical trials.

CANCER LETTERS (2021)

Article Oncology

Amelioration of muscle wasting by gintonin in cancer cachexia

Yoseph Toni Wijaya, Tania Setiawan, Ita Novita Sari, Seung-Yeol Nah, Hyog Young Kwon

Summary: Gintonin (GT) protects against cancer cachexia by reducing oxidative stress and inhibiting inflammation-related genes, showing anti-atrophy effects in muscle cells and a mouse model.

NEOPLASIA (2021)

Meeting Abstract Oncology

TBK1 inhibition potentiates the efficacy of AXL-targeted therapy in aggressive breast cancer preclinical models

Lan Phi, Takashi Semba, Jason Foulks, Steven Warner, David Bearss, Savitri Krishnamurthy, James Long, James Reuben, Debu Tripathy, Naoto Ueno, Xiaoping Wang

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development

Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, Jing Wang, Shan Shao, Francois Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan ThiHanh Phi, Troy Pearson, Jared K. Burks, Evan N. Cohen, James M. Reuben, Fei Yang, Hu Min, Nicholas Navin, Toshiaki Iwase, Yichao Shen, Xiang Zhang, Debu Tripathy, Naoto T. Ueno

CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients

Sooyoun Kim, Doyeon Kim, Sanghyun Roh, Inpyo Hong, Hyeongjoo Kim, Tae Sung Ahn, Dong Hyun Kang, Moon Soo Lee, Moo-Jun Baek, Hyoung Jong Kwak, Chang-Jin Kim, Dongjun Jeong

Summary: This study revealed that SMOX is overexpressed in colorectal cancer and may serve as an important oncogene in CRC. Moreover, SMOX overexpression could be a valuable prognostic marker and potential therapeutic target for CRC.

BIOMEDICINES (2022)

Article Geriatrics & Gerontology

Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway

Yoseph Toni Wijaya, Tania Setiawan, Ita Novita Sari, Keunwan Park, Chan Hee Lee, Kae Won Cho, Yun Kyung Lee, Jae-Young Lim, Jeong Kyo Yoon, Sae Hwan Lee, Hyog Young Kwon

Summary: Ginsenoside Rd (GRd) significantly ameliorates muscle wasting induced by aging and cancer through various mechanisms, demonstrating a potential therapeutic role in reversing muscle wasting in mice.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Oncology

High expression of LY6E is an independent prognostic factor of colorectal cancer patients

Han Jo Kim, Inpyo Hong, Sanghyun Roh, Sooyoun Kim, Hyeongjoo Kim, Seunghyun Oh, Tae Sung Ahn, Dong Hyun Kang, Moo-Jun Baek, Dongjun Jeong

Summary: Colorectal cancer (CRC) is a common and deadly cancer. LY6E, a member of the LY6 family, is highly expressed in CRC and plays a role in CRC recurrence and metastasis. High expression of LY6E is associated with worse overall survival in CRC patients. Knockdown of LY6E inhibits CRC cell proliferation, migration, invasion, and colony formation, suggesting its oncogenic functions and potential as a therapeutic target in CRC.

ONCOLOGY REPORTS (2023)

Article Medicine, General & Internal

The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients

Soohyeon Lee, Dong Hyun Kang, Tae Sung Ahn, Seung Soo Kim, Jong Hyuk Yun, Hyun Jung Kim, Seoung Hee Seo, Tae Wan Kim, Hye Jeong Kong, Moo Jun Baek

Summary: This study analyzed the medical records of 107 patients with stage III colorectal cancer who received adjuvant chemotherapy. Body composition and selected immunonutritional markers were analyzed to determine their impact on chemotherapy adherence. The results showed that skeletal muscle index was positively correlated with chemotherapy adherence, and there were differences in psoas muscle index between high and low adherence groups. Age, white blood cell count, and skeletal muscle index were identified as factors affecting chemotherapy adherence. Adjusting drug dosage based on these factors can improve treatment efficiency.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Prognostic significance of liver CT-attenuation and 18F-FOG uptake for predicting hepatic recurrence following curative resection of colorectal cancer

Jeong Won Lee, Hyein Ahn, Su Jin Jang, Moo-Jun Baek, Nam Hun Heo, Sang Mi Lee

Summary: This study found that computed tomography-attenuation and maximum F-18-FDG uptake in the liver on F-18-FDG PET/CT were significant predictive factors for hepatic RFS in patients with colorectal cancer after curative resection. However, these liver parameters were not significantly associated with extrahepatic RFS.

HELLENIC JOURNAL OF NUCLEAR MEDICINE (2022)

Article Oncology

Prognostic impact of GPR56 in patients with colorectal cancer

Dae-Ro Lim, Dong-Hyun Kang, Jung-Chul Kuk, Tae-Hyung Kim, Eung-Jin Shin, Tae-Sung Ahn, Hyeong-Joo Kim, Dong-Jun Jeong, Moo-Jun Baek, Nam-Kyu Kim

Summary: The study investigated the role of GPR56 in CRC and found that its downregulation affected cell proliferation, invasion, and migration abilities, as well as inhibited colony-forming. High expression of GPR56 was negatively correlated with the overall survival rate of CRC patients, suggesting its potential as a prognostic indicator.

NEOPLASMA (2021)

No Data Available